Aichi, Japan

Yuko Ebihara

This inventor holds 1 USPTO granted patent. Top assignee: Maruko Seiyaku Co., Ltd.. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Ebihara: Innovator in Ergoline Derivatives

Introduction

Yuko Ebihara is a prominent inventor based in Aichi, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on ergoline derivatives. Her research focuses on developing compounds that offer various therapeutic benefits.

Latest Patents

Yuko Ebihara holds a patent for "Ergoline derivatives and acid addition salts thereof." This patent discloses novel ergoline derivatives that exhibit excellent anti-hypertensive activity, vasodilating activity, anti-ulcer activity, gastric secretion inhibitory activity, brain metabolism improving activity, anti-depressive activity, and dopamine-like activity. These properties make her inventions valuable for the prevention and treatment of various diseases, including hypertension, a wide variety of vein disorders, peptic ulcer, brain abnormalities, depression, Parkinson's disease, and high prolactin blood disease.

Career Highlights

Yuko Ebihara is associated with Maruko Seiyaku Co., Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on healthcare and patient outcomes.

Collaborations

Yuko collaborates with notable colleagues, including Kiyoshi Mizukoshi and Mitsuaki Nagasaka, who contribute to her research initiatives and help drive innovation in the field.

Conclusion

Yuko Ebihara's contributions to the development of ergoline derivatives highlight her role as a key innovator in the pharmaceutical industry. Her work not only advances scientific knowledge but also holds promise for improving patient care and treatment options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…